These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 766946)

  • 21. Treatment of solid tumors and lymphomas with methyl-CCNU (NSC-95441): a phase II study.
    Firat D; Tekuzman G
    Cancer Chemother Rep; 1975; 59(5):1021-3. PubMed ID: 1106843
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma.
    Moertel CG; Douglass HO; Hanley J; Carbone PP
    Cancer Treat Rep; 1976 Nov; 60(11):1659-61. PubMed ID: 1035508
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma.
    Ahmann DL; Bisel HF; Edmonson JH; Hahn RG; Eagan RT; O'Connell MJ; Frytak S
    Clin Pharmacol Ther; 1976 Jun; 19(6):821-4. PubMed ID: 773589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.
    Einhorn LH; Furnas B
    Cancer Treat Rep; 1977 Aug; 61(5):881-3. PubMed ID: 329981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma.
    Cohen MH; Schoenfeld D; Wolter J
    Cancer Treat Rep; 1980 Jan; 64(1):151-3. PubMed ID: 6991102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy.
    Zorzitto ML; Myers R; Bazos MJ; Shepherd FA; Evans WK
    Am J Clin Oncol; 1986 Feb; 9(1):27-30. PubMed ID: 3953490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of oral methyl-CCNU and prednisone in previously treated alkylating agent-resistant multiple myeloma.
    Tornyos K; Silberman H; Solomon A
    Cancer Treat Rep; 1977 Aug; 61(5):785-7. PubMed ID: 329977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
    Rossi A; Riva A; Bonadonna G
    Cancer Chemother Rep; 1975; 59(6):1161-2. PubMed ID: 769958
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
    Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
    Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
    Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK
    Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.
    Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK
    Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Fluorouracil, methyl-CCNU, and radiotherapy with or without testolactone for localized adenocarcinoma of the exocrine pancreas: a Southwest Oncology Group Study.
    McCracken JD; Ray P; Heilbrun LK; Vaitkevicius VK; Saiki JH; Rivkin SE; Rossof AH; Moore TN
    Cancer; 1980 Oct; 46(7):1518-22. PubMed ID: 6998556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
    White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
    Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential and combination chemotherapy of advanced gastric cancer.
    Moertel CG; Mittelman JA; Bakemeier RF; Engstrom P; Hanley J
    Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy.
    Micetich KC; Jensen-Akula M; Mandard JC; Fisher RI
    Am J Med; 1981 Dec; 71(6):967-72. PubMed ID: 7032289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
    Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC
    Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU.
    Omura G; DiSaia P; Blessing J; Boronow R; Hreshchyshyn M; Park R
    Cancer Treat Rep; 1977 Nov; 61(8):1533-5. PubMed ID: 922756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma Group.
    Kerbrat P; Somers R; Verweij J; Crowther D; Tursz T; Santoro A; Steward WP; Lentz MA; van Glabbeke M; Mouridsen HT
    Eur J Cancer; 1992; 29A(1):143-4. PubMed ID: 1445732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.